rivastigmine has been researched along with Hemolysis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Markowicz-Piasecka, M; Podsiedlik, M; Sikora, J | 1 |
| Pagar, KP; Sardar, SM; Vavia, PR | 1 |
| Bondì, ML; Casaletto, MP; Craparo, EF; Giammona, G; Licciardi, M; Pitarresi, G | 1 |
3 other study(ies) available for rivastigmine and Hemolysis
| Article | Year |
|---|---|
The Influence of Selected Antipsychotic Drugs on Biochemical Aspects of Alzheimer's Disease.
Topics: Alzheimer Disease; Antipsychotic Agents; Cholinesterase Inhibitors; Endothelial Cells; Hemolysis; Humans; Quetiapine Fumarate; Rivastigmine | 2022 |
Novel L-lactide-depsipeptide polymeric carrier for enhanced brain uptake of rivastigmine in treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cells, Cultured; Depsipeptides; Drug Carriers; Drug Evaluation, Preclinical; Hemolysis; Humans; Male; Materials Testing; Neuroprotective Agents; Phenylcarbamates; Polyesters; Rats; Rats, Wistar; Rivastigmine; Tissue Distribution | 2014 |
A nanoparticulate drug-delivery system for rivastigmine: physico-chemical and in vitro biological characterization.
Topics: Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Drug Delivery Systems; Hemolysis; Humans; Molecular Structure; Nanoparticles; Peptides; Phenylcarbamates; Polyethylene Glycols; Polymethacrylic Acids; Rivastigmine; Triacetin; Ultraviolet Rays | 2008 |